자궁내 피임 기구 시장 : 규모, 점유율, 성장 분석, 유형별, 제품 유형별, 연령층별, 용도별, 지역별, 업계 예측(2026-2033년)

Global Intrauterine Contraceptive Devices Market size was valued at USD 4.6 Billion in 2024 and is poised to grow from USD 4.81 Billion in 2025 to USD 6.9 Billion by 2033, growing at a CAGR of 4.6% during the forecast period (2026-2033).

The global market for Intrauterine Contraceptive Devices (IUDs) is experiencing significant growth driven by heightened awareness of family planning and reproductive health. IUDs are recognized for their effectiveness and low maintenance, providing extended pregnancy protection without daily attention. Their affordability and safety profile appeal to a diverse female demographic, further fueled by governmental and organizational support for maternal health initiatives. The rising demand for hormone-free options has also propelled the market, complemented by technological advancements that enhance user experience. While cultural resistance and myths concerning safety can hinder adoption, particularly in specified regions, the increasing access to healthcare in developing countries presents new opportunities. Despite challenges such as cost and competition from other contraceptives, IUDs remain a preferred choice for many women seeking reliable birth control solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intrauterine Contraceptive Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intrauterine Contraceptive Devices Market Segments Analysis

The Global Intrauterine Contraceptive Devices Market is segmented by Type, Product Type, Age Group, End Use and region. Based on Type, the market is segmented into Hormonal Intrauterine Device and Copper Intrauterine Device. Based on Product Type, the market is segmented into Mirena, Skyla, Paragard, Essure, Levosert and Others. Based on Age Group, the market is segmented into 15-24 years, 25-34 years, 35-44 years and Above 44 years. Based on End Use, the market is segmented into Hospitals, Gynecology Clinics, Community Health Care Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Intrauterine Contraceptive Devices Market

The Global Intrauterine Contraceptive Devices market is significantly driven by the rising preference for long-acting reversible contraceptives, particularly intrauterine devices (IUDs). Women are increasingly choosing these options due to their high efficacy, minimal maintenance, and prolonged effectiveness in pregnancy prevention. With over 99% effectiveness and the ability to last between three to ten years, IUDs offer a convenient alternative to short-term contraceptives. Additionally, healthcare providers frequently recommend these long-acting reversible contraceptive methods as a primary option, further boosting their adoption. Enhanced awareness initiatives highlighting the advantages and reliability of these devices are fostering broader acceptance across diverse populations and regions.

Restraints in the Global Intrauterine Contraceptive Devices Market

The global market for intrauterine contraceptive devices faces significant challenges due to cultural and social factors that hinder their adoption. Despite their medical benefits, many regions remain hesitant to embrace IUDs, largely due to persistent misinformation regarding their safety, impact on fertility, and potential discomfort during insertion. In various cultures, contraception remains a sensitive topic, making it difficult for women to access effective birth control options like IUDs. Additionally, fears surrounding severe side effects and religious objections further complicate acceptance. To improve market penetration, targeted educational initiatives and community outreach programs are essential to raise awareness and enhance acceptance of IUDs among hesitant populations.

Market Trends of the Global Intrauterine Contraceptive Devices Market

The Global Intrauterine Contraceptive Devices market is experiencing a notable shift towards non-hormonal contraceptives, driven by an increasing consumer preference for hormone-free options. As awareness of potential side effects associated with hormonal birth control rises, products like the Copper IUD are gaining traction among health-conscious women seeking long-term solutions that do not disrupt hormonal balance. This trend underscores a growing appetite for non-invasive contraceptive methods that offer comfort and user-friendly designs. Consequently, manufacturers are innovating to enhance the appeal and functionality of non-hormonal IUDs, positioning them as competitive alternatives in the global contraceptive landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis
• Customer & Buying Criteria Analysis

Global Intrauterine Contraceptive Devices Market Size by Type & CAGR (2026-2033)

• Market Overview
• Hormonal Intrauterine Device
• Copper Intrauterine Device

Global Intrauterine Contraceptive Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Mirena
• Skyla
• Paragard
• Essure
• Levosert
• Others

Global Intrauterine Contraceptive Devices Market Size by Age Group & CAGR (2026-2033)

• Market Overview
• 15-24 years
• 25-34 years
• 35-44 years
• Above 44 years

Global Intrauterine Contraceptive Devices Market Size by End Use Industry & CAGR (2026-2033)

• Market Overview
• Hospitals
• Gynecology Clinics
• Community Health Care Centers
• Others

Global Intrauterine Contraceptive Devices Market Size & CAGR (2026-2033)

• North America (Type, Product Type, Age Group, End Use Industry)
  • US
  • Canada
• Europe (Type, Product Type, Age Group, End Use Industry)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product Type, Age Group, End Use Industry)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product Type, Age Group, End Use Industry)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product Type, Age Group, End Use Industry)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Teva Pharmaceutical Industries Ltd. (Jerusalem)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EUROGINE (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HLL Lifecare Limited (Thiruvananthapuram)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OCON Medical Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prosan International BV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Melbea Innovations (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan, Merck & Co., Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DKT International (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisafe Distribution Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medicines360 (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pregna International Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Egemen International (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations